Westin Tom Selected Research

enzalutamide

5/2016	Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.
1/2013	Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Westin Tom Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 05/2016 - 01/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

2	enzalutamideIBA 05/2016 - 01/2013
2	Androgen Receptors (Androgen Receptor)IBA 05/2016 - 01/2013
1	Androgen Receptor AntagonistsIBA 05/2016
1	ChromatinIBA 01/2013
1	AndrogensIBA 01/2013

Therapy/Procedure

2	Castration 05/2016 - 01/2013
1	Therapeutics 01/2013